ioxilan has been researched along with iodixanol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ener, RA; Fiss, D; Georgakis, A; Jin, J; Kunapuli, S; Leech, SH; Van Decker, WA; Wolf, NM | 1 |
| Chow, SL; Kangavari, S; Litwinski, RA; Ng, TM; Weiss, M | 1 |
| Chicaíza-Becerra, LA; Gamboa, Ó; García-Molina, M | 1 |
1 review(s) available for ioxilan and iodixanol
| Article | Year |
|---|---|
Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
Topics: Acute Kidney Injury; Aged; Colombia; Contrast Media; Cost-Benefit Analysis; Decision Trees; Drug Costs; Female; Health Expenditures; Hospitalization; Humans; Insurance, Health, Reimbursement; Iohexol; Iopamidol; Length of Stay; Male; Middle Aged; National Health Programs; Osmolar Concentration; Outpatients; Renal Dialysis; Risk; Triiodobenzoic Acids | 2012 |
2 other study(ies) available for ioxilan and iodixanol
| Article | Year |
|---|---|
Risk of thrombogenicity among nonionic radiocontrast agents.
Topics: Blood Platelets; Cardiac Catheterization; Contrast Media; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Iohexol; Iopamidol; Platelet Aggregation; Risk Factors; Triiodobenzoic Acids | 2008 |
Effect of iodixanol and ioxilan on QT interval and renal function in patients with systolic heart failure.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Electrocardiography; Female; Heart Failure, Systolic; Humans; Iohexol; Kidney; Male; Retrospective Studies; Triiodobenzoic Acids | 2012 |